drugset
Drugs / Influenza A Vaccine H7N3 (6-2) AA ca Recombinant
last change Apr 2009 re-read 3 minutes ago

Influenza A Vaccine H7N3 (6-2) AA ca Recombinant

Vaccine

Developed for
avian influenza
Investigated by
Johns Hopkins Bloomberg School of Public Health · National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

today NCT00516035 · Ph 1
20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00516035 Sep → Dec 2007 avian influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Influenza A Vaccine H7N3 (6-2) AA ca Recombinant ClinicalTrials.gov intervention name — accepted as the source's own label NCT00516035 ↗
Modality Vaccine “a live attenuated H7N3 influenza virus vaccine” PMID 19464558 ↗ Apr 2009
Route Intranasal “administered by nasal spray” NCT00516035 ↗